Inhibition of platelet function by abciximab or high-dose tirofiban in patients with STEMI undergoing primary PCI: a randomised trial
J.W. van Werkum, W.B.M. Gerritsen, J.C. Kelder, C.M. Hackeng, S.M. Ernst, V.H.M. Deneer, M.J. Suttorp, B.J.W.M. Rensing, H.W.M. Plokker, and J.M. ten Berg
Neth Heart J. 2007 November; 15(11): 375–381. PMCID: PMC2082085